Efficacy of Zanubrutinib Versus Acalabrutinib for Relapsed or Refractory Chronic Lymphocytic Leukemia: A Matching-Adjusted Indirect Comparison

}p~G\ yD[D h( `M@a R[5 ,e-- SS!A?Hmv?Xa

Please login or register for full access

Register

Already registered?  Login